Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...

Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Ascendis Pharma (ASND – Research Report) today and set a price target of $180.00. The company’s shares closed last Friday at ...

JPMorgan analyst Yang Huang initiated coverage of Ascentage Pharma (AAPG) with an Overweight rating and HK$52 price target The company’s Olverembatinib, having been approved for three CML ...

EXCLUSIVE: Rob Roy, This Boys Life and Memphis Belle director Michael Caton-Jones is set to helm Eternity from scribes King ...

PG: Pharma has steadily diversified away from a core dependence on blockbuster medicines towards maintaining a healthcare portfolio of products in an attempt to iron out fluctuating sales cycles ...

Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. Most of the major U.S. pharmaceutical companies (AbbVie, Amgen, Bristol Myers ...

LabVantage Pharma is the only pre-configured and pre-validated pharmaceutical LIMS in the world. This greatly lowers the deployment cost (85%) and time (75%) compared to a traditional LIMS ...

Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related ...

Another situation withering away Death of a Unicorn‘s wishful prospects is that it shares first choice with women under 25 with Blumhouse’s PG-13 The Woman in the Yard. Yes, it’s a horror ...

The wellness industry, now worth $6.8 trillion, rivals big pharma in size but faces scrutiny for being unregulated and ripe for scams. While some practices like yoga and acupuncture show benefits ...

The occasion was the 2025 PRWeek Healthcare Awards, a celebration of the sector that crafts the public’s perception of pharmaceutical ... banner emblazoned with logos of corporate sponsors.

HERZLIYA, Israel and CALGARY, AB, March 7, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it has closed its ...